Document:

<PAGE>

                                                                   EXHIBIT 10.63

         AGREEMENT made this 14th day of March 2003, between PolyMedica
Corporation, a Massachusetts corporation (the "Company"), and Samuel L. Shanaman
(the "Participant").

         For valuable consideration, receipt of which is acknowledged, the
parties hereto agree as follows:

         1. Purchase of Shares.

         The Company shall issue and sell to the Participant, and the
Participant shall purchase from the Company, subject to the terms and conditions
set forth in this Agreement and in the Company's 2000 Stock Incentive Plan (the
"Plan"), 3,600 shares (the "Shares") of common stock, $0.01 par value, of the
Company ("Common Stock"), at a purchase price of $0.01 per share. The aggregate
purchase price for the Shares shall be paid by the Participant by check payable
to the order of the Company or such other method as may be acceptable to the
Company. Upon receipt by the Company of payment for the Shares, the Company
shall issue to the Participant one or more certificates in the name of the
Participant for that number of Shares purchased by the Participant. The
Participant agrees that certain of the Shares shall be subject to the purchase
options set forth in Section 2 of this Agreement and the restrictions on
transfer set forth in Section 4 of this Agreement.

         2. Purchase Option.

         Upon the termination of the employment agreement dated as of the date
hereof by and between the Company and the Participant (the "Employment
Agreement"), for any reason or no reason, with or without cause, prior to July
31, 2003, the Company shall have the right and option (the "Purchase Option") to
purchase from the Participant, for a sum of $0.01 per share (the "Option
Price"), some or all of the Unvested Shares (as defined below).

         "Unvested Shares" means the total number of Shares less the total
number of Vested Shares (as defined herein) at the time the Purchase Option
becomes exercisable by the Company. Of the Shares, 1,039 shall be "Vested
Shares" on the date hereof and the remaining 2,561 Shares shall vest on the 30th
day of each month that the Employment Agreement is in effect, beginning March
30, 2003, in an amount determined by multiplying 67 Shares by the number of days
actually worked by the Participant during the period from the last vesting date
to and including the current vesting date. The calculation of Vested Shares to
be made on March 30, 2003 shall be made for the period beginning March 15, 2003.

         3. Exercise of Purchase Option and Closing.

                  a.       The Company may exercise the Purchase Option by
delivering or mailing to the Participant (or his estate), within 60 days after
the termination of the Employment Agreement, a written notice of exercise of the
Purchase Option. Such notice shall specify the number of Shares to be purchased.
If and to the extent the Purchase Option is not so exercised by the giving of
such a notice within such 60-day period, the Purchase Option shall automatically
expire and terminate effective upon the expiration of such 60-day period.

                  b.       Within 10 days after delivery to the Participant of
the Company's notice of the exercise of the Purchase Option pursuant to
subsection (a) above, the Participant (or his estate) shall, pursuant to the
provisions of the Joint Escrow Instructions referred to in Section 5 below,
tender to the Company at its principal offices the certificate or certificates
representing the Shares which the Company has elected to purchase in accordance
with the terms of this Agreement, duly endorsed in blank or with duly endorsed
stock powers attached thereto, all in form suitable for the transfer of such
Shares to the Company. Promptly following its receipt of such certificate or
certificates, the Company shall pay to the Participant the aggregate Option
Price for such Shares (provided that any delay in making such payment shall not
invalidate the Company's exercise of the Purchase Option with respect to such
Shares).

                  c.       After the time at which any Shares are required to be
delivered to the Company for transfer to the Company pursuant to subsection (b)
above, the Company shall not pay any dividend to the Participant on account of
such Shares or permit the Participant to exercise any of the privileges or
rights of a stockholder with respect to such Shares, but shall, in so far as
permitted by law, treat the Company as the owner of such Shares.

                  d.       The Option Price may be payable, at the option of the
Company, in cancellation of all or a portion of any outstanding indebtedness of
the Participant to the Company or in cash (by check) or both.

                  e.       The Company shall not purchase any fraction of a
Share upon exercise of the Purchase Option, and any fraction of a Share
resulting from a computation made pursuant to Section 2 of this Agreement shall
be rounded to the nearest whole

<PAGE>

Share (with any one-half Share being rounded upward).

                  f.       The Company may assign its Purchase Option to one or
more persons or entities.

         4. Restrictions on Transfer.

                  a.       The Participant shall not sell, assign, transfer,
pledge, hypothecate or otherwise dispose of, by operation of law or otherwise
(collectively "transfer") any Shares, or any interest therein, that are subject
to the Purchase Option, except that the Participant may transfer such Shares (i)
to or for the benefit of any spouse, children, parents, uncles, aunts, siblings,
grandchildren and any other relatives approved by the Board of Directors
(collectively, "Approved Relatives") or to a trust established solely for the
benefit of the Participant and/or Approved Relatives, provided that such Shares
shall remain subject to this Agreement (including without limitation the
restrictions on transfer set forth in this Section 4 and the Purchase Option)
and such permitted transferee shall, as a condition to such transfer, deliver to
the Company a written instrument confirming that such transferee shall be bound
by all of the terms and conditions of this Agreement or (ii) as part of the sale
of all or substantially all of the shares of capital stock of the Company
(including pursuant to a merger or consolidation), provided that, in accordance
with the Plan, the securities or other property received by the Participant in
connection with such transaction shall remain subject to this Agreement.

                  b.       The Participant shall have the right, at any time and
from time to time, to pledge or hypothecate the Shares to a commercial bank or
financial institution (the "Bank") as security for a loan from such Bank. During
the term of the pledge or hypothecation agreement, the Company may not exercise
the Purchase Option with respect to the Shares that are subject to the pledge
(the "Pledged Shares"), and if the Participant defaults on such loan, then the
Bank may take possession of the Pledged Shares provided that such Pledged Shares
shall remain subject to this Agreement, other than the Purchase Option which
shall terminate with respect to the Pledged Shares and such permitted transferee
shall, as a condition to such transfer, deliver to the Company a written
instrument confirming that such transferee shall be bound by all of the other
terms and conditions of this Agreement.

         5. Escrow.

                  a.       The Participant shall, upon the execution of this
Agreement, execute Joint Escrow Instructions in the form attached to this
Agreement as Exhibit A. The Joint Escrow Instructions shall be delivered to the
Chief Financial Officer of the Company, as escrow agent thereunder. The
Participant shall deliver to such escrow agent a stock assignment duly endorsed
in blank, in the form attached to this Agreement as Exhibit B, and hereby
instructs the Company to deliver to such escrow agent, on behalf of the
Participant, the certificate(s) evidencing the Shares issued hereunder. Such
materials shall be held by such escrow agent pursuant to the terms of such Joint
Escrow Instructions.

         6. Restrictive Legends.

                  a.       All certificates representing Shares shall have
affixed thereto legends in substantially the following form, in addition to any
other legends that may be required under federal or state securities laws:

                  "The shares of stock represented by this certificate are
subject to restrictions on transfer and an option to purchase set forth in a
certain Restricted Stock Agreement between the corporation and the registered
owner of these shares (or his predecessor in interest), and such Agreement is
available for inspection without charge at the office of the Chief Financial
Officer of the corporation."

         7. Provisions of the Plan.

                  a.       This Agreement is subject to the provisions of the
Plan, a copy of which is furnished to the Participant with this Agreement.

                  b.       As provided in the Plan, upon the occurrence of an
Acquisition Event (as defined in the Plan), the repurchase and other rights of
the Company hereunder shall inure to the benefit of the Company's successor and
shall apply to the cash, securities or other property which the Shares were
converted into or exchanged for pursuant to such Acquisition Event in the same
manner and to the same extent as they applied to the Shares under this
Agreement. If, in connection with an Acquisition Event, a portion of the cash,
securities and/or other property received upon the conversion or exchange of the
Shares is to be placed into escrow to secure indemnification or similar
obligations, the mix between the vested and unvested portion of such cash,
securities and/or other property that is placed into escrow shall be the same as
the mix between the vested and unvested portion of such cash, securities and/or
other property that is not subject to escrow.

         8. Withholding Taxes; Section 83(b) Election.

                  a.       The Participant acknowledges and agrees that the
Company has the right to deduct from payments of any

<PAGE>

kind otherwise due to the Participant any federal, state or local taxes of any
kind required by law to be withheld with respect to the purchase of the Shares
by the Participant or the lapse of the Purchase Option.

                  b.       The Participant has reviewed with the Participant's
own tax advisors the federal, state, local and foreign tax consequences of this
investment and the transactions contemplated by this Agreement. The Participant
is relying solely on such advisors and not on any statements or representations
of the Company or any of its agents. The Participant understands that the
Participant (and not the Company) shall be responsible for the Participant's own
tax liability that may arise as a result of this investment or the transactions
contemplated by this Agreement. The Participant understands that it may be
beneficial in many circumstances to elect to be taxed at the time the Shares are
purchased rather than when and as the Company's Purchase Option expires by
filing an election under Section 83(b) of the Code with the I.R.S. within 30
days from the date of purchase.

                  THE PARTICIPANT ACKNOWLEDGES THAT IT IS THE PARTICIPANT'S SOLE
RESPONSIBILITY AND NOT THE COMPANY'S TO FILE TIMELY THE ELECTION UNDER SECTION
83(b), EVEN IF THE PARTICIPANT REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO
MAKE THIS FILING ON THE PARTICIPANT'S BEHALF.

         9. Miscellaneous.

                  a.       No Rights to Employment. The Participant acknowledges
and agrees that the vesting of the Shares pursuant to Section 2 hereof is earned
only by continuing service pursuant to the Employment Agreement (not through the
act of being hired or purchasing shares hereunder). The Participant further
acknowledges and agrees that the transactions contemplated hereunder and the
vesting schedule set forth herein do not constitute an express or implied
promise of continued engagement as an employee or consultant for the vesting
period, for any period, or at all.

                  b.       Severability. The invalidity or unenforceability of
any provision of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement, and each other provision of this
Agreement shall be severable and enforceable to the extent permitted by law.

                  c.       Waiver. Any provision for the benefit of the Company
contained in this Agreement may be waived, either generally or in any particular
instance, by the Board of Directors of the Company.

                  d.       Binding Effect. This Agreement shall be binding upon
and inure to the benefit of the Company and the Participant and their respective
heirs, executors, administrators, legal representatives, successors and assigns,
subject to the restrictions on transfer set forth in Section 4 of this
Agreement.

                  e.       Notice. All notices required or permitted hereunder
shall be in writing and deemed effectively given upon personal delivery or five
days after deposit in the United States Post Office, by registered or certified
mail, postage prepaid, addressed to the other party hereto at the address shown
beneath his or its respective signature to this Agreement, or at such other
address or addresses as either party shall designate to the other in accordance
with this Section 9(e).

                  f.       Pronouns. Whenever the context may require, any
pronouns used in this Agreement shall include the corresponding masculine,
feminine or neuter forms, and the singular form of nouns and pronouns shall
include the plural, and vice versa.

                  g.       Entire Agreement. This Agreement and the Plan
constitute the entire agreement between the parties, and supersede all prior
agreements and understandings, relating to the subject matter of this Agreement.

                  h.       Amendment. This Agreement may be amended or modified
only by a written instrument executed by both the Company and the Participant.

                  i.       Governing Law. This Agreement shall be construed,
interpreted and enforced in accordance with the internal laws of the
Commonwealth of Massachusetts without regard to any applicable conflicts of
laws.

                  j.       Participant's Acknowledgments. The Participant
acknowledges that he or she: (i) has read this Agreement; (ii) has been
represented in the preparation, negotiation, and execution of this Agreement by
legal counsel of the Participant's own choice or has voluntarily declined to
seek such counsel; (iii) understands the terms and consequences of this
Agreement; (iv) is fully aware of the legal and binding effect of this
Agreement; and (v) understands that the law firm of Hale and Dorr LLP, is acting
as counsel to the Company in connection with the transactions contemplated by
the Agreement, and is not acting as counsel for the Participant.

<PAGE>

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
day and year first above written.

                                            POLYMEDICA CORPORATION

                                            By: /s/ Stephen C. Farrell
                                                ----------------------
                                            Name: Stephen C. Farrell
                                            Title: Senior Vice President and
                                                   Chief Financial Officer

                                            /s/ Samuel L. Shanaman
                                            --------------------------
                                            Name: Samuel L. Shanaman
                                            Title: Lead Director and Interim
                                                   Chief Executive Officer<PAGE>

                                                                   EXHIBIT 10.64

         This Agreement (the "Agreement") is entered into and is effective as of
the 6th day of June, 2003, by and between Eric G. Walters ("Executive"),
PolyMedica Corporation, a Massachusetts Corporation (the "Company"), and the
Board of Directors of the Company (the "Board of Directors").

BACKGROUND

         The Company, through its Board of Directors, has determined that a
partial reorganization of operations is appropriate at this time to meet
challenges and take advantage of opportunities presented by current market
conditions. This reorganization includes, among other things, the elimination of
the position of Executive Vice President now held by Executive. The Company has
offered Executive the option to resign his employment with the Company on terms
which reflect his long service and substantial contribution to the growth and
success of the Company. Executive, after careful consideration of the Company's
offer and his professional goals, believes that the most attractive
opportunities for his personal professional development exist outside the
Company, and has decided to resign his employment at the conclusion of an
appropriate transitional period to facilitate the Company's reorganization
plans. This important business decision is taking place at a time when the
Company is the subject of government civil and criminal investigations and civil
litigation, as noted in section 4.1 of this Agreement. It is of great importance
to both the Board of Directors and the Executive that the resignation of the
Executive not be interpreted by others as the product of a finding of
impropriety as to the Executive. Such an interpretation would be inaccurate. The
Company has neither resolved, nor is it determined to attempt to resolve some or
all of the proceedings in which it is currently involved by offering to provide
information to third parties concerning the Executive. The existence of the
proceedings was not the basis for the decision by the Board to implement a
partial reorganization which eliminates Executive's position or to accept the
Executive's resignation.

RECITALS

         WHEREAS Executive and the Company previously entered into an Executive
Retention Agreement dated as of September 1, 2000 and an Amended Executive
Employment Agreement dated April 1, 2001, as amended on June 8, 2001, September
25, 2001, May 13, 2002, and July 15, 2002 (collectively, all of the foregoing
agreements shall be referred to as the "Previous Agreements");

         WHEREAS Executive and the Company desire for this Agreement to
supersede all Previous Agreements as of the effective date of Executive's
resignation; and

         WHEREAS Executive and the Company acknowledge that this Agreement is
desirable and would not otherwise be entered into unless the Agreement
supersedes the Previous Agreements as of the effective date of Executive's
resignation;

         WHEREAS Executive and the Company desire for this Agreement to resolve
amicably and on mutually satisfactory terms any and all issues relating to the
Executive's resignation from employment with the Company;

         WHEREAS Executive desires to resign his position as Clerk, Disclosure
Committee Member, and Chief Compliance Officer on the date hereof and as
Executive Vice President on August 15, 2003 and the Company recognizes
Executive's valuable service to the Company;

         NOW THEREFORE, in consideration of the mutual promises and forbearances
set forth in this Agreement, and other good and valuable consideration which
Executive and the Company hereby acknowledge, Executive and the Company agree as
follows:

TERMS AND CONDITIONS

1.       BACKGROUND AND RECITALS. The foregoing Background and Recitals are
incorporated into and made a part of the Terms and Conditions of the Agreement.

2.       RESIGNATION OF EMPLOYMENT. Executive resigns his position with the
Company as Clerk, Disclosure Committee Member, and Chief Compliance Officer
effective as of the date of this Agreement. Executive shall, however, remain
employed as Executive Vice President through August 15, 2003 or such sooner time
as determined by Executive ("Date of Separation"), at which time Executive
agrees to execute and deliver the Resignation Letter attached hereto as Exhibit
A.

3.       SEVERANCE BENEFITS.

         3.1      OFFICER SEVERANCE PAY.

                  (a)      As of the Date of Separation, the Company shall pay
Executive salary continuation at his current base salary

<PAGE>

for eighteen (18) months, less all state and federal taxes ("Severance"). The
Severance shall be paid in accordance with the Company's normal payroll
procedures, but in no event shall payment start earlier than the first regular
payroll after the end of the Revocation Period for the Release of Claims
executed by Executive.

                  (b)      The Company shall, within five business days of the
Date of Separation, pay to Executive any accrued unpaid salary. In addition, the
Company shall pay Executive accrued unpaid bonus for FY2004 of $33,750 (less
applicable tax withholdings).

                  (c)      The Company shall within five business days of the
Date of Separation pay to Executive the amount due to him (less applicable tax
withholdings) for his 42.0 days of accrued, unused vacation.

         3.2      HEALTH INSURANCE. For a period of 18 months after the Date of
Separation, or until the Executive becomes employed, whichever occurs first, the
Company shall offer Executive continued health and dental insurance as required
under the Consolidated Omnibus Budget Reconciliation Act of 1985 ("COBRA"), or
other law, and shall reimburse Executive for the full cost of that coverage.

         3.3      EQUIPMENT. Executive shall be entitled to permanent ownership
of the Brother fax machine he currently uses in his home office.

         3.4      LIFE INSURANCE. For a period of 18 months after the Date of
Separation or until Executive becomes employed, whichever occurs first, the
Company shall continue in full force and effect, at its expense, life insurance
on the life of the Executive with an Executive-directed beneficiary in the
amount of $405,000.

         3.5      NOTICE. Executive shall be obligated to provide the Company
prompt notice of his subsequent employment.

         3.6      401(K) PLANS.

                  (a)      Executive is a participant in the Company's
non-qualified 401(k) shadow plan/social security equalization plan/pension
plan/deferred salary and bonus plan (the "SERP") and has a fully vested account
balance in the SERP. Executive shall continue to participate in the SERP through
the Date of Separation and the Company shall credit additional amounts to his
SERP account based on his salary through the Date of Separation and accrued
unpaid bonus for FY2004. As soon as practicable and in no event later than
October 1, 2003, the Company shall cause: (1) the full amount in Executive's
SERP account (less applicable tax withholdings) to be paid to him in a lump sum;
and (2) to be delivered to Executive a schedule of all activity (e.g.
contributions and investments) in his account from April 1, 2003 through the
effective date of such payment.

                  (b)      After the Date of Separation, Executive shall be
entitled to roll-over any and all existing 401(k) retirement account(s),
including discretionary amounts contributed by the Company, pursuant to the
applicable benefit plan provisions.

         3.7      OUTPLACEMENT. Executive shall be reimbursed for the cost of
outplacement services provided by an outplacement consultant of Executive's
choice up to a maximum of twenty-five thousand dollars.

4.       INDEMNIFICATION AND NO ADVERSE ACTION.

         4.1      The Company acknowledges Executive's rights as an Indemnitee
under the Articles of Organization (the "Articles") of the Company. Without
limitation of the foregoing, the Company acknowledges that it has received
proper notice, in accordance with Section 3 of Article 6F of the Articles, of
Executive's claim that he has a right to be indemnified with respect to the
following matters:

                  -        In re: PolyMedica Corp. Sec. Litig., Civ. A. No.
                           00-12426 REK, United States District Court, District
                           of Massachusetts

                  -        In re: PolyMedica Corp. Shareholder Derivative
                           Litig., Civ. A. No. 01-3446, Superior Court of
                           Middlesex County, Commonwealth of Massachusetts

                  -        The investigations currently being conducted by the
                           United States Attorney's for the Southern District of
                           Florida and the Southern District of Illinois

         The Company further acknowledges that, pursuant to such Section 3, the
Company has authorized Executive to employ Kirkpatrick & Lockhart LLP as his
counsel with respect to the civil matters set forth above, and Robert C.
Josefsberg with respect to the criminal matters set forth above. This
acknowledgement shall not limit in any way the right of the Executive to employ
his own counsel with respect to other indemnified claims, as provided in such
Section 3.

<PAGE>

         4.2      The Company acknowledges that, pursuant to Section 4 of
Article 6F and subject to the last sentence of this Section 4.2, it is
obligated, subject to the terms and conditions of such Section 4, to pay the
reasonable expenses of the Executive incurred in connection with the matters
listed in Section 4.1 above. The Company hereby agrees that the Executive may
instruct his attorneys to forward their invoices for fees and expenses that are
considered expenses under such Section 4 directly to the Company and the Company
shall pay such fees and expenses within 30 days.

         Executive, in order to comply with the provisions of such Section 4 and
with Massachusetts law, hereby undertakes to repay all amounts so advanced in
the event that it shall ultimately be determined that the Executive is not
entitled to be indemnified by the Company in accordance with the Articles.

         4.3      The Company currently maintains Directors and Officers
liability insurance, the policies for which will be made available to the
Executive and his authorized representatives promptly following any request
therefore. The Company shall use commercially reasonable efforts to keep such
policies in effect as to the Executive after the date hereof.

5.       NON-DISPARAGEMENT.

         5.1      The Company, the Senior Executives and Directors agree not to
take any action or make any statement which is false, disparages, criticizes, or
is derogatory with respect to, Executive regardless of whether such statements
would be actionable under statutory or common law liability theories.

         5.2      The Executive understands and agrees that he shall not make
any false, disparaging or derogatory statements to any media outlet, industry
group, financial institution, investor, current or former employee, consultant,
client or customer of the Company or any other third party, regarding the
Company or any of its directors, officers, employees, attorneys, agents or
representatives or about the Company's business affairs or financial condition.
The Executive further agrees not to make any statement of any kind to any media
outlet other than what has been mutually agreed upon as a press release with the
Company.

         5.3      The parties recognize that the Company may provide information
to a Governmental Entity (as defined below) or plaintiffs, as the case may be,
on a voluntary basis. Nothing in this agreement shall be construed to limit or
impede such voluntary cooperation or anyone acting on behalf of the Company from
providing any information, including but not limited to documents, witnesses,
and/or information obtained from any witness, on a voluntary basis. Nor shall it
be construed to limit or impede anyone acting on behalf of the Company from
responding to any legal process. For purposes of this agreement the term
"Governmental Entity" shall mean any court, arbitrational tribunal,
administrative agency or commission or other governmental or regulatory
authority, agency or instrumentality, any entity charged by a Governmental
Entity with the administration of a government program, or any stock market or
stock exchange on which shares of the Company's stock are traded.

         5.4      The parties agree that Sections 5.1, 5.2 and 5.3 may be
specifically enforced by Executive or the Company, as applicable, it being
agreed that money damages are not an adequate remedy for breach of Sections 5.1,
5.2 or 5.3.

6.       COOPERATION.

         6.1      The Executive agrees to cooperate fully with the Company in
the defense or prosecution of any claims or actions or investigations which
already have been brought, including, but not limited to, In Re: PolyMedica
Corp. Sec. Litig., Civil Action No. 00-12426 REK pending in the United States
District Court for the District of Massachusetts, and In Re: PolyMedica Corp.
Shareholder Derivative Lit., Civil Action No. 01-3446 pending in the Superior
Court of Middlesex County for the Commonwealth of Massachusetts, any inquiries
by the United States Securities & Exchange Commission, any grand jury
investigation or other investigation currently being conducted by the United
States Attorney's Office for the Southern District of Florida, or the Southern
District of Illinois, or any claims or actions which may be brought in the
future against, or on behalf of or involving the Company wherein the Executive
is indemnified by the Company, whether before or by a state or federal court or
by any local, state or federal government agency. The Executive's full
cooperation in connection with such claims or actions shall include, but not be
limited to, his being available to meet with counsel to prepare its claims or
defenses, to prepare for trial or discovery or an administrative hearing and to
act as a witness when requested by the Company at reasonable times designated by
the Company. Executive agrees to appear voluntarily before any grand jury
proceeding relating to any of the matters set forth in Section 4 above, unless
(a) Executive is a subject or target of said grand jury and (b) Executive has
not been granted formal immunity. By agreeing to cooperate Executive does not
waive any of his constitutional rights or attorney-client or attorney work
product privileges and any assertion of such rights or privileges shall not be
considered a violation of this Agreement. The Executive agrees that he will
notify the Company promptly and in writing in the event that he is served with a
subpoena or other such request for information or documents from a third party
concerning the Company.

         6.2      The Company agrees that the Company and its lawyers will
cooperate with Executive by providing him and his lawyers with reasonable access
to copies of all business records of the Company, to which the Executive would
have been entitled to

<PAGE>

access in the ordinary course of business during the period in which Executive
was employed by the Company, that are necessary to the Executive's defense of
the proceedings described in Section 4.1 above or any other indemnified activity
for so long as such proceedings continue.

7.       NON-DISCLOSURE AND NON-COMPETITION. The Executive acknowledges and
reaffirms his obligations with respect to intellectual property and
non-competition, as stated more fully in the Confidentiality and Proprietary
Information Agreement dated May 16, 1990 (the "Confidentiality Agreement") and
the Agreement Not To Compete dated May 16, 1990 (the "Non-Compete Agreement"),
each of which remains in full force and effect; provided however, that the
Company agrees that if Executive wishes to engage in activities or render
services prohibited by the Non-Compete Agreement, Executive may request, in a
letter to the General Counsel of the Company describing generally the services
he wishes to render and identifying the entity for whom he seeks to provide such
services, a release from the Agreement Not To Compete. The decision whether or
not to release Executive from his obligations under the Agreement Not to Compete
shall be in the Company's discretion, which decision will be reviewable in the
discretion of a single arbitrator at the Executive's request pursuant to the
commercial arbitration rules of the American Arbitration Association in
Massachusetts.

8.       RETURN OF COMPANY PROPERTY. On the Date of Separation, the Executive
agrees to return all Company property in good working order which has been
provided to Executive including, but not limited to, keys, files, records (and
copies thereof), equipment (including, but not limited to, computer hardware,
software and printers, cellular phones, pagers, etc.), Company identification
and any other Company-owned property which is in his possession or control and
to advise the Company of any password protected identification that he has
placed on or used in connection with any document or file on the Company's
computer system and any necessary actions required to facilitate the Company's
access to all documents on the computer system. Further, Executive agrees to
leave intact all electronic Company documents, including those he developed or
helped develop during his employment and to cancel all accounts for his benefit,
if any, in the Company's name, including but not limited to, credit cards,
telephone charge cards, cellular phone and/or pager accounts and computer
accounts and to delete all Company files or records on any personal computer on
which he stored such information.

9.       CONFIDENTIALITY. To the extent permitted by law, the Executive
understands and agrees that the contents of the negotiations and discussions
resulting in this Agreement shall be maintained as confidential by the
Executive, his attorneys, agents and representatives, and none of the above
shall be disclosed except to the extent required by federal or state law or as
otherwise agreed to in writing by the authorized agent of each party.

10.      RELEASES.

         10.1     The Executive agrees to execute and deliver to the Company the
Release attached hereto as Exhibit B on the Date of Separation.

         10.2     The Company agrees to execute and deliver to the Executive the
Release attached hereto as Exhibit C on the Date of Separation.

         10.3     Nothing contained in the releases set forth in Sections 10.1
and 10.2 above shall be deemed to defeat the right, if any, of any issuer or
underwriter of directors' and officers' liability insurance for PolyMedica and
its directors and officers to recover monies on a theory of subrogation,
indemnification or contribution.

11.      VOLUNTARY ASSENT. The Executive affirms that no other promises or
agreements of any kind have been made to or with him by any person or entity
whatsoever to cause him to sign this Agreement, and that he fully understands
the meaning and intent of this Agreement. The Executive states and represents
that he has had an opportunity to fully discuss and review the terms of this
Agreement with an attorney. The Executive further states and represents that he
has carefully read this Agreement, understands the contents herein, freely and
voluntarily assents to all of the terms and conditions hereof, and signs his
name of his own free act.

12.      NATURE OF AGREEMENT. The parties understand and agree that this
Agreement does not constitute an admission of liability or wrongdoing on the
part of the Company or the Executive.

13.      ATTORNEYS' FEES. The Company agrees to reimburse Executive for the
attorneys' fees and expenses incurred by him in connection with the preparation
of this Agreement, up to a maximum of twenty thousand dollars, within 30 days
after presentation to the Company of invoices reflecting such fees and expenses.
The Company further agrees that any reasonable attorneys' fees and expenses
incurred by Executive in connection with a dispute regarding this Agreement
shall be reimbursed to the extent and only in proportion to the claim(s) on
which the Executive prevails in the dispute.

14.      STOCK CERTIFICATES AND TRADES.

         14.1     The Company shall reissue, as soon as practicable but in no
event later than five (5) business days after the Date of

<PAGE>

Separation, in Employee's or his designee's name and without legends, all
legended stock certificates representing shares of the Company's common stock
beneficially owned by Employee. In connection with such reissuance(s), the
Company shall obtain at its expense any legal opinion it deems necessary or
advisable.

         14.2     The Company agrees to prepare and file with the Securities and
Exchange Commission on a timely basis all reports required to be filed by
Employee pursuant to Section 16 of Securities Exchange Act of 1934, as amended,
and the rules and regulations promulgated thereunder; provided that Employee
reports to the Company all of his transactions in the Company's securities
triggering the filing of such a report no later than the initiation of such a
transaction. Executive acknowledges that he is responsible for promptly and
accurately reporting any transactions to the Company and that the Company is not
responsible for any liability arising from its filing of such reports at the
request of Executive.

15.      MISCELLANEOUS.

         15.1     ENTIRE AGREEMENT. This Agreement contains the entire
understanding of Executive and the Company in respect of its subject matter and
supersedes all prior oral or written agreements or understandings between
Executive and the Company with respect to such subject matter; provided however,
that the Previous Agreements shall remain in effect through the Separation Date
and that the Non-Compete Agreement and the Confidentiality Agreement shall
remain in effect as set forth in Section 7 above.

         15.2     AMENDMENT; WAIVER. This Agreement may not be amended,
supplemented, cancelled or discharged, except by written instrument executed by
all parties. No failure to exercise, and no delay in exercising, any right,
power or privilege hereunder shall operate as a waiver thereof. No waiver of any
breach of any provision of this Agreement shall be deemed to be a waiver of any
preceding or succeeding breach of the same or any other provision.

         15.3     BINDING EFFECT; ASSIGNMENT. The rights and obligations of this
Agreement shall bind any successor of the Company by reorganization, merger,
acquisition or consolidation, or any assignee of all or substantially all of the
Company's business and properties. The Company will require any successor to all
or substantially all of the business and/or assets of the company (whether
direct or indirect, by purchase, merger, consolidation, asset or stock
acquisition or otherwise) to assume expressly and agree to perform this
Agreement in the same manner and to the same extent that the Company would be
required to perform if no such succession had taken place. As used in this
Agreement, `the Company" shall mean the Company as hereinbefore defined and any
successor to all or substantially all of its business and/or assets as aforesaid
which assumes and agrees to perform this Agreement by operation of law or
otherwise. The Company agrees to require any such successor to acknowledge its
obligation pursuant to this Agreement in a binding written agreement approved by
Executive prior to such transaction.

         15.4     HEADINGS. The headings contained in this Agreement are for
reference purposes only and shall not affect the meaning or interpretation of
this Agreement.

         15.5     APPLICABLE LAW. This Agreement shall be interpreted and
construed by the laws of the Commonwealth of Massachusetts, without regard to
conflict of laws provisions. Executive hereby irrevocably submits and
acknowledges and recognizes the jurisdiction of the courts of the Commonwealth
of Massachusetts, or if appropriate, a federal court located in Massachusetts
(which courts, for purposes of this Agreement, are the only courts of competent
jurisdiction), over any suit, action or other proceeding arising out of, under
or in connection with this Agreement or the subject matter hereof.

         15.6     FURTHER ASSURANCES. The Company and Executive agree to
execute, acknowledge, deliver and perform, or cause to be executed,
acknowledged, delivered or performed, at any time, or from time to time, as the
case may be, all such further documents, acts, deeds, assignments, transfers,
conveyances, powers of attorney and assurances as may be necessary or proper to
carry out the provisions or intent of this Agreement.

         15.7     SEVERABILITY. If any one or more of the terms, provisions,
covenants or restrictions of this Agreement shall be determined by a court of
competent jurisdiction to be invalid, void or unenforceable, the remainder of
the terms, provisions, covenants and restrictions of this Agreement shall remain
in full force and effect and shall in no way be affected, impaired or
invalidated. If, moreover, any one or more of the provisions contained in this
Agreement shall for any reason be determined by a court of competent
jurisdiction to be excessively broad as to duration, geographical scope,
activity or subject, it shall be construed by limiting or reducing it so as to
be enforceable to the extent compatible with then applicable law.

EXECUTION

         The parties executed this Agreement as a sealed instrument as of the
date first above written, whereupon it becomes binding in accordance with its
terms.

<PAGE>

                                            POLYMEDICA CORPORATION

                                            /s/ Arthur A. Siciliano
                                            -----------------------
                                            Arthur A. Siciliano
                                            President

                                            Then personally appeared the above
                                            named Arthur A. Siciliano and
                                            acknowledged the foregoing
                                            instrument to be his free act and
                                            deed on behalf of PolyMedica
                                            Corporation, before me,

                                            /s/ Karen M. Meyer, Notary Public
                                            ---------------------------------
                                            My commission expires: 3/26/2010

                                            For purposes of Section 5.4:

AGREED TO AND ACCEPTED:                     BOARD OF DIRECTORS

/s/ Eric G. Walters                         /s/ Samuel L. Shanaman
-------------------                         ----------------------
Eric G. Walters                             Samuel L. Shanaman
                                            Lead Director, on behalf of the
                                            Board of Directors

Then personally appeared the above          Then personally appeared the above
named Eric G. Walters, and acknowledged     named Samuel L. Shanaman and
the foregoing instrument to be his free     acknowledged the foregoing
act,                                        instrument to be his free act and
                                            deed on behalf of the Board of
                                            Directors of PolyMedica Corporation,
                                            before me,

/s/ Karen M. Meyer, Notary Public
---------------------------------
My commission expires: 3/26/2010            /s/ Karen M. Meyer, Notary Public
                                            ---------------------------------
                                            My commission expires: 3/26/2010

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}]]